BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 23148804)

  • 1. Retinoids in the chemoprevention of non-melanoma skin cancers: why, when and how.
    Bettoli V; Zauli S; Virgili A
    J Dermatolog Treat; 2013 Jun; 24(3):235-7. PubMed ID: 23148804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic retinoids in chemoprevention of non-melanoma skin cancer.
    Lens M; Medenica L
    Expert Opin Pharmacother; 2008 Jun; 9(8):1363-74. PubMed ID: 18473710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinoid chemoprevention in the high-risk patient.
    DiGiovanna JJ
    J Am Acad Dermatol; 1998 Aug; 39(2 Pt 3):S82-5. PubMed ID: 9703130
    [No Abstract]   [Full Text] [Related]  

  • 4. [Systemic retinoids (acitretin, isotretinoin)].
    Berbis P
    Ann Dermatol Venereol; 2007 Dec; 134(12):935-41. PubMed ID: 18166914
    [No Abstract]   [Full Text] [Related]  

  • 5. Systemic retinoids: chemoprevention of skin cancer in transplant recipients.
    Hardin J; Mydlarski PR
    Skin Therapy Lett; 2010; 15(7):1-4. PubMed ID: 20700551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uses and complications of isotretinoin therapy.
    Ellis CN; Krach KJ
    J Am Acad Dermatol; 2001 Nov; 45(5):S150-7. PubMed ID: 11606947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin cancer chemoprevention with systemic retinoids: an adjunct in the management of selected high-risk patients.
    Campbell RM; DiGiovanna JJ
    Dermatol Ther; 2006; 19(5):306-14. PubMed ID: 17014486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuromuscular adverse effects associated with systemic retinoid dermatotherapy: monitoring and treatment algorithm for clinicians.
    Chroni E; Monastirli A; Tsambaos D
    Drug Saf; 2010 Jan; 33(1):25-34. PubMed ID: 20000864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depression and acitretin: a true association or a class labeling?
    Hayes J; Koo J
    J Drugs Dermatol; 2011 Apr; 10(4):409-12. PubMed ID: 21455552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized controlled trial of acitretin versus placebo in patients at high-risk for basal cell or squamous cell carcinoma of the skin (North Central Cancer Treatment Group Study 969251).
    Kadakia KC; Barton DL; Loprinzi CL; Sloan JA; Otley CC; Diekmann BB; Novotny PJ; Alberts SR; Limburg PJ; Pittelkow MR
    Cancer; 2012 Apr; 118(8):2128-37. PubMed ID: 21882176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic and topical retinoids in the management of skin cancer in organ transplant recipients.
    De Graaf YG; Euvrard S; Bouwes Bavinck JN
    Dermatol Surg; 2004 Apr; 30(4 Pt 2):656-61. PubMed ID: 15061851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Topical and Systemic Retinoids in Solid Organ Transplant Recipients: Update and Review of the Current Literature.
    Herold M; Good AJ; Nielson CB; Longo MI
    Dermatol Surg; 2019 Dec; 45(12):1442-1449. PubMed ID: 31403546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic retinoids for chemoprevention of non-melanoma skin cancer in high-risk patients.
    Marquez C; Bair SM; Smithberger E; Cherpelis BS; Glass LF
    J Drugs Dermatol; 2010 Jul; 9(7):753-8. PubMed ID: 20677528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral retinoids for the prevention of skin cancers in solid organ transplant recipients: a systematic review of randomized controlled trials.
    Chen K; Craig JC; Shumack S
    Br J Dermatol; 2005 Mar; 152(3):518-23. PubMed ID: 15787821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoic acid receptor agonist as monotherapy for early-stage mycosis fungoides: does it work?
    Amitay-Laish I; Reiter O; Prag-Naveh H; Kershenovich R; Hodak E
    J Dermatolog Treat; 2019 May; 30(3):258-263. PubMed ID: 29889596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoprevention of skin cancer in xeroderma pigmentosum.
    Kraemer KH; DiGiovanna JJ; Peck GL
    J Dermatol; 1992 Nov; 19(11):715-8. PubMed ID: 1293159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of retinoids in the prevention and treatment of skin cancer.
    Niles RM
    Expert Opin Pharmacother; 2002 Mar; 3(3):299-303. PubMed ID: 11866680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative tolerability of systemic treatments for plaque-type psoriasis.
    McClure SL; Valentine J; Gordon KB
    Drug Saf; 2002; 25(13):913-27. PubMed ID: 12381213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic strategies for chemoprevention of skin cancers in transplant recipients.
    Kovach BT; Sams HH; Stasko T
    Clin Transplant; 2005 Dec; 19(6):726-34. PubMed ID: 16313317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoprevention of nonmelanoma skin cancer with systemic retinoids: practical dosing and management of adverse effects.
    Otley CC; Stasko T; Tope WD; Lebwohl M
    Dermatol Surg; 2006 Apr; 32(4):562-8. PubMed ID: 16681667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.